Tate & Lyle targets dairy drink boom
A range of functional ingredients solutions has been launched by Tate & Lyle, as it looks to capitalise on consumer demand for healthy yoghurts and dairy drinks.
Archives for February 6, 2007
ReGen raises funds for further Colostrinin development
ReGen Therapeutics is today issuing over 150m new shares to raise £1.1m, in part to fund ongoing development of its Colostrinin nutraceutical that is expected to be commercialised this year.
Omega-3-rich flaxseed oil may lower blood pressure
A diet rich in the plant omega-3 alpha-linolenic acid (ALA) reduced blood pressure by up to six per cent, says new research from Greece.
Report gives ingredient insight by health indication
A new report from Business Insights is turning the spotlight on science to support the efficacy of healthy ingredients, a preoccupation for food and drink manufacturers in the present climate of shifting health claims regulations.
Herbalife gets investors' confidence in proposed buy-out
Dietary supplements marketer Herbalife received a $38-a-share offer from private-equity firm Whitney & Company - who already own 27 percent of its stock - and Monday the company's shares had already inched up to $40.12.
Academic comes down on vitamins and current regulation
An American Journal of Clinical Nutrition article, based on last year's NIH State of the Science conference, has suggested that building scientific standards into supplements legislation could be a way to reward companies making science-based marketing.
FDA due to expand oat heart health claim
Oat products with a higher fat content could be eligible to carry a heart health claim, according to a new proposal by the US Food and Drug Administration (FDA).
Raising vitamin D intake could lower breast, colorectal cancer risk
Increasing the daily intake of vitamin D to 2000 International Units could halve the risk of developing breast and colorectal cancer, two studies have reported.